Neuphoria Therapeutics Inc. business relationships

Companies named in Neuphoria Therapeutics Inc.’s 10-K filed 2026-09-18, and public companies whose annual reports name Neuphoria Therapeutics Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.

Open on the map Full AI visibility profile

AEO visibility: 4.7 / 10
AI naming: 26 / 100
Agent readiness: 0 / 100
AI adoption: 0 / 100

Named in Neuphoria Therapeutics Inc.’s annual report 8

Merck & Co., Inc. (MRK)Licensee7.7
“This work produced BNC210 and the alpha7 PAM program, which we licensed to Merck.” SEC filing
PFIZER INC (PFE)Licensee7.7
“Through our participation in the former CTx CRC, we retain a passive economic interest in a KAT6 program licensed to Pfizer.” SEC filing
Merck & Co., Inc. (MRK)Licensor7.7
“Under the 2014 Merck License Agreement, Merck is responsible for using commercially reasonable efforts to develop, file for marketing authorization for and, following receipt thereof, to commercialize at least one product thereunder.” SEC filing
PFIZER INC (PFE)Licensor7.7
“...ipants Agreement and associated CRC Commercialization License Agreements (including the existing license agreement with Pfizer relating to KAT6), for a period of 15 years from Completion; (iii) pursuant to any monetization of certain of the Company's intellectual property rights within the applicabl...” SEC filing
Merck & Co., Inc. (MRK)Partner7.7
“The Merck collaboration includes two clinical-stage alpha7 receptor PAM candidates.” SEC filing
Merck & Co., Inc. (MRK)Supplier7.7
“Our information rights are limited, and we depend on Merck for updates concerning development, safety and regulatory matters.” SEC filing
IRONWOOD PHARMACEUTICALS INC (IRWD)Licensor6.1
“Further, in connection with the termination of our previous research and license agreement with Ironwood Pharmaceuticals, Inc. ("Ironwood"), we are obligated to pay Ironwood a low to mid-single digit royalty on the net sales of BNC210, if commercialized.” SEC filing
Carina Biotech Pty LtdLicensor4.6
“In November 2020, the Company entered into an IP license agreement (the "Carina Biotech License") with Carina Biotech Pty Ltd ("Carina Biotech").” SEC filing

Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.